Snowball logo
logo
RMD_logo

ResMed Inc

RMD β€’ NYSE
$226.74+$0.74Β  (0.33%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
3,578.14,2234,685.35,146.35,653.45,653.4
COGS
1,553.81,867.32,0302,091.42,201.72,201.7
Gross Profit
2,024.32,355.72,655.33,0553,451.73,451.7
Operating Expenses & Income
Operating Income
1,000.31,131.91,319.91,685.41,886.71,892.7
Total Operating Expenses
1,0241,223.81,335.41,369.61,5651,565
R&D Expenses
253.6287.6307.5331.3378.3378.3
Selling General & Admin Expenses
739.4874917.1991-823.2
Earnings from Continuing Operations
Interest Expense
(22.31)(47.38)(45.71)(12.61)(49.91)(49.91)
Interest Income
4344.7251.62.541-13.86
Income Tax Expense
181204.1243.8276.8396.1396.1
Net Income
Net Income
779.4897.61,0211,400.71,523.31,523.3
Supplemental
EBIT
982.81,162.31,317.31,677.6-1,660
EBITDA
1,176.61,358.81,533.51,913.41,886.71,886.7
In millions of USD, except % and values per 1 share